ProfileGDS4814 / ILMN_1740927
TitleOvarian cancer xenograft tumor response to trastuzumab and pertuzumab
OrganismHomo sapiens


none trastuzumab pertuzumab trastuzumab and pertuzumab GSM780707 GSM780708 GSM780709 GSM780719 GSM780720 GSM780721 GSM780710 GSM780711 GSM780712 GSM780722 GSM780723 GSM780724 GSM780713 GSM780714 GSM780715 GSM780725 GSM780726 GSM780727 GSM780716 GSM780717 GSM780718 GSM780728 GSM780729 83% 83% 82% 83% 84% 83% 83% 82% 83% 82% 83% 82% 83% 82% 81% 83% 83% 84% 83% 84% 83% 83% 81% sort by agent Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM780707Untreated after 4 days (C1_1)185.0183
GSM780708Untreated after 4 days (C2_1)194.59483
GSM780709Untreated after 4 days (C3_1)174.85382
GSM780719Untreated after 4 days (C1_2)182.33383
GSM780720Untreated after 4 days (C2_2)205.19684
GSM780721Untreated after 4 days (C3_2)198.17583
GSM780710Trastuzumab treated after 4 days (T1_1)193.36483
GSM780711Trastuzumab treated after 4 days (T2_1)174.13782
GSM780712Trastuzumab treated after 4 days (T3_1)197.41783
GSM780722Trastuzumab treated after 4 days (T1_2)177.32782
GSM780723Trastuzumab treated after 4 days (T2_2)187.56383
GSM780724Trastuzumab treated after 4 days (T3_2)180.33882
GSM780713Pertuzumab treated after 4 days (P1_1)186.34883
GSM780714Pertuzumab treated after 4 days (P2_1)170.23382
GSM780715Pertuzumab treated after 4 days (P3_1)159.1981
GSM780725Pertuzumab treated after 4 days (P1_2)192.55183
GSM780726Pertuzumab treated after 4 days (P2_2)189.36683
GSM780727Pertuzumab treated after 4 days (P3_2)199.56884
GSM780716Trastuzumab and Pertuzumab treated after 4 days (TP1_1)185.483
GSM780717Trastuzumab and Pertuzumab treated after 4 days (TP2_1)207.50784
GSM780718Trastuzumab and Pertuzumab treated after 4 days (TP3_1)190.02183
GSM780728Trastuzumab and Pertuzumab treated after 4 days (TP1_2)197.04383
GSM780729Trastuzumab and Pertuzumab treated after 4 days (TP2_2)163.67581